Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Noninvasive Prenatal Testing (NIPT) Market -
Global industry Perspective, Comprehensive
Analysis and Forecast, 2014 - 2020
3422 SW 15 Street, Suit #8138,
Florida 33442, USA
Toll Free: 1-855-465-4651
Noninvasive prenatal testing (NIPT) is also known as noninvasive prenatal diagnosis (NIPD). Non-
invasive prenatal testing (NIPT) market is used for screening pregnant women at high risk of developing
fetal chromosomal aneuploidies such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome)
and trisomy 13 (Patau syndrome) or a sex chromosome irregularity, such as Turner syndrome. The
testing can also be used to determine a baby's sex and rhesus (Rh) blood type. The Non-Invasive
Prenatal Test (NIPT) is a DNA test on maternal blood to screen for the fetal aneuploidies (chromosomes
21, 18, 13) during pregnancy. Now, noninvasive prenatal testing is only available for women who have
certain risk issue. Non-invasive prenatal testing (NIPT) offers harmony, verifi, Panorama, informaSeq,
VisibiliT, PrenaTest, BambniTest and other test.
The NIPT market is growing, due to rising healthcare expenditure. The common maternal age is rising in
high income countries, owing to varying pattern of employment, education and marriage and growing
price of raising a child. The increase in common maternal age is resulting in the development of the
global NIPT market. The exponential growth of the NIPT market is supported by factors such as high
birth rate with Down syndrome, no risk of miscarriage with NIPT, and shifting trend toward child bearing
at advanced maternal age.
Browse the full "Noninvasive Prenatal Testing (NIPT) Market -Global industry Perspective,
Comprehensive Analysis and Forecast, 2014 - 2020" report at
The report includes detailed competitive landscape of the global Non-Invasive Prenatal Test market and
an analysis of Porter’s five forces model for the Non-Invasive Prenatal Test market has also been
included. It includes company market share analysis, product portfolio of the major industry participants.
The report provides detailed segmentation of the Non-Invasive Prenatal Test market based on Test and
region segment. Bambni test, harmony, informaSeq, materniT21 PLUS, NIFTY, panorama, PrenaTest,
verifi, VisibiliT is the Test of Non-Invasive Prenatal Test market. MaterniT21 PLUS was the most
conventional test in the market and led the total market.
Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin
America, and Middle East and Africa with its further bifurcation into major countries including U.S.,
Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for Non-
Invasive Prenatal Test based on individual products and applications in all the regions and countries. The
market is expected to be driven by the demand from untapped regions such as Europe and Asia Pacific
during the forecast period.
The report covers detailed competitive outlook including company profiles of the key participants
operating in the global market. Key players profiled in the report include Sequenom Inc., BGI, LabCorp,
LifeCodexx AG, Natera Inc., Quest Diagnostics Incorporated, Illumina Inc., Berry Genomics, Ariosa
Diagnostics and Hoffmann-La Roche Ltd.
Access sample report visit at http://www.syndicatemarketresearch.com/request-for-
Noninvasive Prenatal Testing (NIPT)Market: Test Segment Analysis
Browse the full "Noninvasive Prenatal Testing (NIPT) Market -Global industry
Perspective, Comprehensive Analysis and Forecast, 2014 - 2020" report at
Syndicate Market Research
Address: Suite #8138, 3422 SW 15 Street, Deerfield Beach, Florida 33442, USA
Tel: +1-855-465-4651 (US/CAN TOLL FREE)
Web : www.syndicatemarketresearch.com